SEC Form 4 · accession 0001140361-15-043157
RESMED INC · RMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Pendarvis
Officer — Chief Administrative Officer
Period of report
Nov 3, 2015
Accepted (ET)
Nov 30, 2015 · 7:56 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000943819
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| ResMed Common StockF3,F4 | Nov 3, 2015 | M | 5,585 | $25.54 | A | 79,872 | D | |
| ResMed Common StockF4 | Nov 3, 2015 | S | 5,585 | $58.09 | D | 74,287 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ResMed Common Stock OptionsF2 | $25.54 | Nov 3, 2015 | M | 5,585 | D | Dec 17, 2010 | Dec 17, 2016 | ResMed Common Stock | 5,585 | 0 | D |
Explanation of responses
- F1The transaction was conducted under a 10b5-1 Plan as defined under the Securities Exchange Act of 1934, as amended.
- F2Represents date options first became exercisable. Options vest 1/4 per year on the anniversary of the grant.
- F3Includes 207.2194 shares purchased on October 30, 2015, through ResMed's Employee Stock Purchase Plan.
- F4The number of shares reported in Column 5 is the number of shares beneficially owned as of the date of this filing and takes into account transactions reported on Form 4 since the date of the transaction reported herein.